BioCentury
ARTICLE | Clinical News

COH29: Phase I started

July 11, 2016 7:00 AM UTC

City of Hope and Novonco began an open-label, dose-escalation, U.S. Phase I trial to evaluate oral COH29 twice daily on days 1-21 of each 28-day cycle in about 27 patients. Last year, City of Hope gra...